[Secondary stroke prevention according to the PRoFESS Study. What are the sequelae for practical therapy?].
作者信息
Diener Christoph
出版信息
MMW Fortschr Med. 2008 May 22;150(21):7.
PMID:18578065
Abstract
摘要
相似文献
1
[Secondary stroke prevention according to the PRoFESS Study. What are the sequelae for practical therapy?].
MMW Fortschr Med. 2008 May 22;150(21):7.
2
[ASS plus dipyridamole or clopidogrel after stroke: what is the best secondary prevention?].
MMW Fortschr Med. 2008 May 22;150(21):6-7.
3
4
[Platelet-function inhibitors in the secondary prevention of ischemic stroke].
Dtsch Med Wochenschr. 2006 Nov;131 Suppl 5:S132-4. doi: 10.1055/s-2006-955052.
5
[PRoFESS study presented. Change in secondary prevention].
MMW Fortschr Med. 2003 May 26;145 Suppl 2:96-7.
6
The PRoFESS trial results: what went wrong?
Int J Stroke. 2008 Aug;3(3):165-6. doi: 10.1111/j.1747-4949.2008.00212.x.
7
Newer antiplatelet therapies in stroke prevention.
Aust Fam Physician. 2001 Feb;30(2):129-34.
8
Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Int J Clin Pract. 2007 Oct;61(10):1739-48. doi: 10.1111/j.1742-1241.2007.01515.x.
9
Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
J Neurol Sci. 2009 Sep 15;284(1-2):1-9. doi: 10.1016/j.jns.2009.04.001. Epub 2009 Apr 19.
10
[Combination of acetylsalicylic acid with dipyridamole is better than acetylsalicylic acid monotherapy].
Med Monatsschr Pharm. 2006 Nov;29(11):421-3.
Zotero 插件